Skip to main content
Premium Trial:

Request an Annual Quote

Waters Shares Sink 21 Percent After Company Cuts Q1 Earnings Projections

NEW YORK, March 30 (GenomeWeb News) - Shares in Waters today tumbled 21 percent, or $9.71, at $36.55 in mid-afternoon trading one day after the company said it would revise its projected first quarter earnings from $.44 to between $.34 and $.37 per diluted share.

In a 
statement, Waters said that the lowered earnings were the result of "weaker than expected sales growth." The firm had anticipated a 13 to 14 percent increase in sales during a conference call with investors in January, but revised that projection to a 3 to 4 percent increase yesterday.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.